Agenus Company Profile (NASDAQ:AGEN)

Analyst Ratings

Consensus Ratings for Agenus (NASDAQ:AGEN) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.33 (104.02% upside)

Analysts' Ratings History for Agenus (NASDAQ:AGEN)
Show:
DateFirmActionRatingPrice TargetActions
7/29/2016Jefferies GroupBoost Price TargetBuy$6.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2016Maxim GroupReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/31/2015Oppenheimer Holdings Inc.Reiterated RatingPositive -> Outperform$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015MLV & Co.Reiterated RatingBuy$9.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Agenus (NASDAQ:AGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/25/2016        
7/28/2016Q216($0.34)($0.33)$5.12 million$6.59 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016Q116($0.23)($0.37)$5.16 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2016Q415($0.17)($0.18)$9.39 million$7.64 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315($0.15)($0.16)$7.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215($0.15)($0.44)$5.71 million$6.38 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115($0.01)($0.28)$11.66 million$3.95 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414($0.16)($0.41)$1.62 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2014Q314($0.15)($0.13)$1.96 million$1.56 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214($0.17)($0.12)$3.07 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.13)($0.01)$0.55 million$0.72 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014Q413($0.24)($0.16)$870.00 million$393.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313($0.27)($0.24)$736.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013($0.21)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q4 2012($0.24)($0.23)$0.72 million$1.09 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011($0.05)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Agenus (NASDAQ:AGEN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.18)($0.18)($0.18)
Q2 20161($0.39)($0.39)($0.39)
Q3 20161($0.44)($0.44)($0.44)
Q4 20161($0.47)($0.47)($0.47)
Q1 20171($0.24)($0.24)($0.24)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.25)($0.25)($0.25)
Q4 20171($0.25)($0.25)($0.25)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Agenus (NASDAQ:AGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Agenus (NASDAQ:AGEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/9/2016Garo H ArmenCEOBuy100,000$3.18$318,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Ozer BaysalInsiderBuy2,250$3.10$6,975.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Garo H ArmenCEOBuy200,000$4.03$806,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2015Garo H. ArmenCEOSell219,576$4.59$1,007,853.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2015Garo H. ArmenCEOSell134,352$4.60$618,019.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2015Charles Evan BallantyneCFOBuy10,000$5.05$50,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2015Garo H ArmenCEOBuy100,000$5.03$503,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Shahzad MalikDirectorSell1,107,377$7.11$7,873,450.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Qvt Associates Gp LlcMajor ShareholderSell2,343,630$5.31$12,444,675.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/23/2014Karen ValentineVPSell2,850$3.50$9,975.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Agenus (NASDAQ:AGEN)
DateHeadline
07/29/16 07:52 PMJefferies & Co disclosed (NASDAQ:AGEN) Agenus Inc, increasing its price target to $7 earlier today
07/29/16 02:21 PMBiotech Stocks To Put On Your Watch List: Agenus Inc. (NASDAQ:AGEN), Adverum Biotechnologies, Inc. (NASDAQ ... - The Voice Registrar
07/29/16 02:21 PMStock Analysis review: Agenus Inc. (NASDAQ:AGEN) - News Oracle
07/29/16 02:21 PMAgenus Inc. (AGEN) Jumps 9.13% on July 28 - Equities.com
07/29/16 02:21 PMHC Wainwright Weighs In on Agenus Inc (AGEN) Following 2Q:16 Update - Smarter Analyst
07/29/16 08:47 AMAgenus (AGEN) Posts Narrower than Expected Loss in Q2 -
07/28/16 03:20 PMAgenus Inc Earnings Call (Q2 2016)
07/28/16 10:59 AMAgenus Inc.: Agenus Reports Second Quarter 2016 Financial Results and Operational Progress - The Wall Street Transcript
07/28/16 10:00 AMAgenus Inc Earnings Call scheduled for 11:00 am ET today -
07/28/16 09:43 AMAgenus (AGEN) Reports Narrower-than-Expected Q2 Loss -
07/28/16 08:08 AMAgenus Reports Second Quarter 2016 Financial Results and Operational Progress - [at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company developing antibodies, including checkpoint inhibitors and other checkpoint modulators, and cancer vaccines, ...
07/28/16 08:01 AMAgenus reports 2Q loss -
07/27/16 10:54 AMHot Biotech Stocks Recap: Heat Biologics, Inc. (NASDAQ:HTBX ... - The Voice Registrar
07/25/16 07:08 AMAgenus (AGEN): What's Ahead for the Stock in Q2 Earnings?
07/22/16 02:21 PMCould Agenus Inc Decline After Today's Huge Increase? - Press Telegraph
07/21/16 11:12 AMEarnings Focus and Crowd Sourced Sentiment Review for Agenus Inc. (NASDAQ:AGEN) - TGP
07/21/16 11:12 AMAgenus Inc. (AGEN) Drops 5.63% on July 19 - Equities.com
07/21/16 07:50 AMAgenus to Report Second Quarter 2016 Financial Results on July 28, 2016; Conference Call to Follow - [Business Wire] - Agenus Inc. will release its second quarter 2016 financial results before the market opens on Thursday, July 28, 2016. Agenus executives will host a conference call at 11 a.m.
07/19/16 02:22 PMAgenus Inc. (NASDAQ:AGEN): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/19/16 01:31 PMIs Agenus or Ariad Pharmaceuticals the Better Long-Term Buy? -
07/19/16 08:33 AMHow Many Agenus Inc (NASDAQ:AGEN)'s Analysts Are Bullish? - Consumer Eagle
07/19/16 08:33 AMForm 8-K AGENUS INC For: Jul 14 - StreetInsider.com
07/19/16 07:51 AMAGENUS INC Files SEC form 8-K, Change in Directors or Principal Officers -
07/18/16 02:23 PM2 Biotech Stocks News And Price Trends: Agenus Inc. (NASDAQ:AGEN), Gilead Sciences Inc. (NASDAQ:GILD) - The Voice Registrar
07/18/16 07:12 AMTrading Performance and Target Watch for Agenus Inc. (NASDAQ:AGEN) - Press Telegraph
07/18/16 07:12 AMShare Performance Summary for: Agenus Inc. (NASDAQ:AGEN) - Press Telegraph
07/18/16 07:12 AMCan Agenus Inc. (NASDAQ:AGEN) Meet Analysts Expectations? - Stocks Daily
07/17/16 07:07 AMAgenus, Inc. – Product Pipeline Review – 2016 Market research, rising demands to drive global industry growth - Medgadget (blog)
07/15/16 12:57 PMAgenus Inc. (AGEN) Updated Price Targets - FTSE News
07/14/16 02:22 PMAgenus Inc Realized Volatility Hits Elevated Level - CML News
07/14/16 02:22 PMAgenus Inc Realized Volatility Hits Elevated Level - CML News
07/14/16 11:12 AMImmune Check Activators- Competitive Landscape, Technology and Pipeline Analysis, 2016; New Report Launched
07/13/16 02:22 PMTrading the Biotech News: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar
07/13/16 10:26 AMGlobal Cytotoxic T-Lymphocyte Protein 4 (CTLA-4 or CD152) Pipeline Review 2016 - Research and Markets
07/12/16 07:50 PMAgenus Inc. (NASDAQ:AGEN) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 07:50 PMAgenus Inc. (NASDAQ:AGEN) Insider Activities Are in the Air - Review Fortune
07/12/16 02:23 PMAnalyst Recommended Stock: Agenus Inc. (NASDAQ:AGEN) - News Oracle
07/10/16 02:20 PMNext Weeks Broker Price Targets For Agenus Inc. (AGEN) - Fiscal Standard
07/08/16 07:33 PMAgenus Inc (NASDAQ:AGEN) Institutional Investor Positioning Change - Engelwood Daily
07/08/16 02:22 PMAgenus Inc. (AGEN) Jumps 5.16% on July 07 - Equities.com
07/08/16 02:22 PMMost recent Analysts Rating report: Envision Healthcare Holdings, Inc. (NYSE:EVHC) , Agenus Inc. (NASDAQ:AGEN) - Street Updates
07/07/16 02:22 PMAgenus Inc. Stock Momentum Hits Strength - CML News
07/06/16 08:05 PMInsiders Increasing Positions in: Agenus Inc. (NASDAQ:AGEN) - Press Telegraph
07/06/16 02:22 PMStock Tracking Down This Month; Investor Alert on Agenus Inc. (NASDAQ:AGEN) - Engelwood Daily
07/06/16 02:22 PMIncreased Volatility Watch for: Agenus Inc. (NASDAQ:AGEN) - Engelwood Daily
07/06/16 10:31 AMAGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
07/06/16 08:21 AMAgenus Appoints Jean-Marie Cuillerot, M.D. as Vice President and Global Head of Clinical Development - [at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company developing antibodies, including checkpoint inhibitors and other checkpoint modulators, and cancer vaccines, ...
07/04/16 07:08 AMAgenus Inc. (AGEN) Broker Price Targets For The Coming Week - Fiscal Standard
07/01/16 02:22 PMNew Broker Ratings For Agenus Inc. (AGEN) - FTSE News
06/30/16 07:49 PMVaccine Adjuvants Market - Forecasts to 2021 - New Market Report

Social

About Agenus

Agenus logoAgenus Inc. (Agenus) is an immunotherapy company. The Company is engaged in discovering and developing treatments for patients with cancer and other diseases. Its approaches are driven by three platform technologies: Its antibody platform, including Retrocyte Display technology, which is designed to produce human monoclonal antibodies focused on advancing checkpoint modulators (CPMs); its heat shock protein (HSP)-based vaccines, and its saponin-based vaccine adjuvants, QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company has a portfolio of programs in pre-clinical and clinical stages, including a series of CPMs in investigational new drug (IND)-enabling studies, Prophage Series vaccine, a Phase III ready HSP-based autologous vaccine for glioblastoma multiforme (GBM), which is a form of brain cancer, and a number of QS-21 Stimulon-containing vaccine candidates in late stage development by its partner, GlaxoSmithKline (GSK).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AGEN
  • CUSIP: 00847G70
Key Metrics:
  • Previous Close: $5.55
  • 50 Day Moving Average: $4.43
  • 200 Day Moving Average: $3.85
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $482.20M
  • Beta: 2.12
  • Current Year EPS Consensus Estimate: $-1.4 EPS
  • Next Year EPS Consensus Estimate: $-1.35 EPS
Additional Links:
Agenus (NASDAQ:AGEN) Chart for Saturday, July, 30, 2016